Free shipping on all orders over $ 500

ML324

Cat. No. M8409
ML324 Structure
Size Price Availability Quantity
10mg USD 95  USD95 In stock
50mg USD 305  USD305 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

ML324 is a potent JMJD2 demethylase inhibitor that is highly effective in reducing herpes simplex virus (HSV) IE gene expression. ML324 potently blocks the initiation of viral lytic infection and HSV-1 reactivation in the sensory ganglia of latently infected mice.

Chemical Information
Molecular Weight 349.43
Formula C21H23N3O2
CAS Number 1222800-79-4
Form Solid
Solubility (25°C) DMSO: 10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] So Young Kim, et al. Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells

[2] Robert Kleszcz, et al. The inhibitors of KDM4 and KDM6 histone lysine demethylases enhance the anti-growth effects of erlotinib and HS-173 in head and neck cancer cells

[3] Janette Reader, et al. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box

[4] Joy E Kirkpatrick, et al. Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesis

[5] Ganesha Rai, et al. Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity

Related Histone demethylase Products
INCB059872

INCB059872 is a potent, orally active, selective and irreversible inhibitor of lysine-specific demethylase 1 (LSD1) in myeloid leukemia.

KDM2A/7A-IN-1

KDM2A/7A-IN-1 is a first-in-class, selective, cell-permeable inhibitor of the histone lysine demethylase KDM2A/7A, with an IC50 value of 0.16 μM for KDM2A, 75-fold more selective than other JmjC lysine demethylases, and with no effect on methyltransferases or histone acetyltransferases. KDM2A was 75 times more selective than other JmjC lysine demethylases and had no effect on methyltransferases and histone acetyltransferases.

NCD38 TFA

NCD38 TFA is a LSD1-selective inhibitor.

LSD1-IN-26

LSD1-IN-26 is a potent LSD1 inhibitor, with an IC50 of 25.3 nM.

JMJD6-IN-1

JMJD6-IN-1 is a JMJD6 inhibitor, with an inhibition rate of 82% at 10 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: ML324 supplier, Histone demethylase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.